Institutional investors hold a majority ownership of PDLI through the 90.57% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $2.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 1.4 Thousand shares of PDL BioPharma Inc
WADE FINANCIAL GROUP, INC. Bought 12.00 shares of PDL BioPharma Inc